Immediate Impact
69 standout
Citing Papers
T cell malignancies after CAR T cell therapy in the DESCAR-T registry
2025 Standout
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
Works of Lesa Gardner being referenced
Results of the X-PECT study: A phase III randomized double-blind placebo-controlled study of perifosine plus capecitabine (P-CAP) versus placebo plus capecitabine (CAP) in patients (pts) with refractory metastatic colorectal cancer (mCRC).
2012
Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer
2011
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Lesa Gardner | 166 | 94 | 74 | 12 | 229 | |
| J. Infante | 153 | 136 | 49 | 17 | 269 | |
| Gregory Malnassy | 144 | 70 | 36 | 14 | 266 | |
| Robin Meng | 65 | 115 | 71 | 9 | 228 | |
| Lieve Adriaens | 181 | 162 | 73 | 14 | 299 | |
| Yasuyuki Kaneta | 168 | 74 | 43 | 10 | 282 | |
| Alberto Arnulfo | 144 | 37 | 53 | 12 | 282 | |
| Yanan Min | 74 | 43 | 178 | 12 | 293 | |
| Leila Kokabee | 163 | 78 | 41 | 15 | 280 | |
| Daniel Kukral | 104 | 68 | 23 | 9 | 264 | |
| Tao Osgood | 154 | 177 | 21 | 13 | 297 |
All Works
Loading papers...